Meigata K, Hondo R, Fujima A, Shinkai-Shibata M, Itoh S, Kikuchi K, Ando Y, Ichikawa N, Nomura Y, Watanabe K, Degawa H, Beck Y, Tomikawa S, Nagao T, Uchida H
Department of Surgery and Organ Transplantation, University of Tokyo.
Jpn J Med Sci Biol. 1996 Jun;49(3):121-7. doi: 10.7883/yoken1952.49.121.
We titrated human cytomegalovirus (HCMV) DNA in urine specimens obtained from 14 healthy individuals and a renal transplant patient with HCMV pneumonitis by modifying the method for titration of varicella-zoster virus DNA previously described (1,2). Of 14 HCMV seropositive healthy individuals, 13 had HCMV DNA under the detection limit of 10(2.0) copies/ml, whereas one person had 10(2.0) copies/ml. The viral DNA in urine samples was at a low level in healthy individuals with latent infection. In a case with HCMV pneumonitis after renal transplantation, the amount of HCMV DNA in urine gradually increased from the level under 10(2.0) copies/ml and reached a peak of 10(4.7) copies/ml one month prior to the manifestation of pneumonitis. It, thereafter, decreased with the course of clinical remission, and finally settled at under 10(2.0) copies/ml. Serial titrations of HCMV DNA in urine specimens proved to be useful in identifying recipients at risk of developing active HCMV infection after renal transplantation and as a guide for treatment of patients.
我们通过改进先前描述的水痘-带状疱疹病毒DNA滴定方法(1,2),对从14名健康个体和1名患有巨细胞病毒肺炎的肾移植患者获得的尿液标本中的人巨细胞病毒(HCMV)DNA进行了滴定。在14名HCMV血清阳性的健康个体中,13人的HCMV DNA低于10(2.0)拷贝/毫升的检测限,而1人有10(2.0)拷贝/毫升。在潜伏感染的健康个体中,尿液样本中的病毒DNA水平较低。在1例肾移植后发生巨细胞病毒肺炎的病例中,尿液中HCMV DNA的量从低于10(2.0)拷贝/毫升的水平逐渐增加,在肺炎表现前1个月达到10(4.7)拷贝/毫升的峰值。此后,随着临床缓解过程而下降,最终稳定在低于10(2.0)拷贝/毫升。尿液标本中HCMV DNA的系列滴定被证明有助于识别肾移植后有发生活动性HCMV感染风险的受者,并作为患者治疗的指导。